Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
County asks consultants to model coverage options for GLP‑1 weight‑loss drugs; commissioners cautious about adding benefit now
Summary
After a presentation by consultants on GLP‑1 medications used for diabetes and weight management, commissioners directed staff to return with modeled cost‑sharing options and implementation scenarios rather than adding coverage immediately.
Monroe County employee‑benefits staff and consultants from Gallagher briefed commissioners on GLP‑1 agonist medications — a drug class used to treat type‑2 diabetes and, more recently, indicated for chronic weight management. The consultants reviewed clinical approvals, typical annual drug costs, likely utilization scenarios and controls available through the county’s pharmacy benefit manager.
Gallagher noted the medicines are effective but expensive: branded options for the weight‑loss indication have list prices in…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
